Integer (NYSE:ITGR) and Manhattan Scientifics (OTCMKTS:MHTX) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, profitability, earnings, dividends and valuation.

Valuation and Earnings

This table compares Integer and Manhattan Scientifics’ revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Integer $1.46 billion 1.75 $66.67 million $2.81 28.16
Manhattan Scientifics $140,000.00 38.13 $1.54 million N/A N/A

Integer has higher revenue and earnings than Manhattan Scientifics.

Profitability

This table compares Integer and Manhattan Scientifics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Integer 14.12% 12.78% 4.44%
Manhattan Scientifics N/A -46.94% -30.12%

Insider and Institutional Ownership

96.1% of Integer shares are owned by institutional investors. Comparatively, 0.2% of Manhattan Scientifics shares are owned by institutional investors. 3.6% of Integer shares are owned by insiders. Comparatively, 11.8% of Manhattan Scientifics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Volatility and Risk

Integer has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.Comparatively, Manhattan Scientifics has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Integer and Manhattan Scientifics, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer 0 1 3 0 2.75
Manhattan Scientifics 0 0 0 0 N/A

Integer currently has a consensus target price of $84.50, indicating a potential upside of 6.80%. Given Integer’s higher possible upside, analysts clearly believe Integer is more favorable than Manhattan Scientifics.

Summary

Integer beats Manhattan Scientifics on 9 of the 11 factors compared between the two stocks.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates through two segments, Medical and Non-Medical. The company offers arthroscopic devices and components, such as shaver blades and burrs, ablation probes, and suture anchors; laparoscopic and general surgery products, including trocars, endoscopes and laparoscopes, closure devices, harmonic scalpels, bipolar energy delivery devices, radio frequency probes, thermal tumor ablation devices, and ophthalmic surgery devices; and biopsy and drug delivery products. It also provides orthopedic products, including hip and shoulder joint reconstruction implants, plates, screws, and spinal devices, as well as instruments and delivery systems. In addition, the company provides products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products. Further, it offers cardiac and neuromodulation products, such as batteries, capacitors, filtered and unfiltered feedthroughs, engineered components, implantable stimulation leads, and enclosures; pacemakers, implantable cardiac defibrillators, cardiac resynchronization therapy devices, implantable cardiac monitors, and other implantable devices; and neuromodulation medical devices. Additionally, it offers customized battery power and management systems, charging and docking stations, and power supplies for energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. The company was founded in 1970 and is headquartered in Frisco, Texas.

Manhattan Scientifics Company Profile

Manhattan Scientifics, Inc., a technology incubator company, focuses on the technology transfer and commercialization of transformative technologies in the areas of nanotechnology applications in medicine in the United States. It develops cancer detection technology and nanostructured metal technologies. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.